Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Genetic Variants Associated with High Plasma Levels of Factor VIII and Von Willebrand Factor in a Family with Thrombotic Episodes

Silvia Spena, Andrea Cairo, Francesca Gianniello, Emanuela Pappalardo, Mimosa Mortarino, Isabella Garagiola, Ida Martinelli, Flora Peyvandi

Blood (2023) 142 (Supplement 1): 5402.

https://doi.org/10.1182/blood-2023-189383

Published: 2023

Journal Articles

Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis

Frits R. Rosendaal, Roberta Palla, Isabella Garagiola, Pier M. Mannucci, Flora Peyvandi

Blood (2017) 130 (15): 1757–1759.

https://doi.org/10.1182/blood-2017-06-791756

Published: 2017

Includes: Supplemental data

Journal Articles

Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A

Antonino Cannavò, Carla Valsecchi, Isabella Garagiola, Roberta Palla, Pier Mannuccio Mannucci, Frits R. Rosendaal, Flora Peyvandi

Blood (2017) 129 (10): 1245–1250.

https://doi.org/10.1182/blood-2016-06-720086

Published: 2017

Includes: Supplemental data

Journal Articles

Genetic Risk Stratification to Minimize Inhibitor Risk with the Use of Recombinant Factor VIII Concentrates: A Sippet Analysis

Frits Rosendaal, MD PhD, Roberta Palla, PhD, Isabella Garagiola, PhD, Piermannuccio Mannucci, MD, Flora Peyvandi, MD PhD

Blood (2016) 128 (22): 325.

https://doi.org/10.1182/blood.V128.22.325.325

Published: 2016

Journal Articles

Risk Differential in Inhibitor Development in the First Days of Treatment By Product Class: A Sippet Analysis

Flora Peyvandi, MD PhD, Antonino Cannavò, MD, Isabella Garagiola, PhD, Roberta Palla, PhD, Frits Rosendaal, MD PhD, Piermannuccio Mannucci, MD

Blood (2016) 128 (22): 330.

https://doi.org/10.1182/blood.V128.22.330.330

Published: 2016

Journal Articles

Whole-exome sequencing to identify genetic risk variants underlying inhibitor development in severe hemophilia A patients

Marcin M. Gorski, Kevin Blighe, Luca A. Lotta, Emanuela Pappalardo, Isabella Garagiola, Ilaria Mancini, Maria Elisa Mancuso, Maria Rosaria Fasulo, Elena Santagostino, Flora Peyvandi

Blood (2016) 127 (23): 2924–2933.

https://doi.org/10.1182/blood-2015-12-685735

Published: 2016

Journal Articles

Source of Factor VIII Replacement (PLASMATIC OR RECOMBINANT) and Incidence of Inhibitory Alloantibodies in Previously Untreated Patients with Severe Hemophilia a: The Multicenter Randomized Sippet Study

Flora Peyvandi, MD PhD, Pier Mannuccio Mannucci, MD, Isabella Garagiola, PhD, Mohsen Elalfy, MD, Amal El-Beshlawy, MD, Madatha V. Ramanan, MD, Peyman Eshghi, MD, Suresh Hanagavadi, Ramabadran Varadarajan, MD, Mehran Karimi, MD, Mamta V. Manglani, MD, Cecil Ross, MD, Guy Young, MD, Tulika Seth, MD, Shashikant Apte, MD FRCPA, Dinesh M. Nayak, MD, Adriana C. Sandoval Gonzales, MD, Elena Santagostino, MD PhD, Maria Elisa Mancuso, MD PhD, Johnny N. Mahlangu, MD, Santiago Bonanad, PhD, Monica Cerqueira, MD, Nadia P. Ewing, MD, Christoph Male, MD MSC, Tarek Owaidah, MD FRCPA, Veronica Soto Arellano, MD, Nathan L. Kobrinsky, MD FRCP, Suvankar Majumdar, MD, Rosario Perez Garrido, MD, Anupam Sachdeva, Mindy Simpson, MD FAAP, Mathew Thomas, Ezio Zanon, MD, ALI Bulent Antmen, Kaan Kavakli, MD, Marilyn Manco-Johnson, MD, Monica Martinez, MD, Esperanza Marzouka, MS, PS, Maria Gabriella Mazzucconi, MD, Daniela Neme, MD, Angeles Palomo Bravo, MD, Rogelio Paredes Aguilera, MD, Alessandra Nunes Loureiro Prezotti, MD, Schmitt Klaus, MD, Brian M. Wicklund, MD MPH, Bulent Zulfikar, MD, Rosendaal R. Frits, MD PhD

Blood (2015) 126 (23): 5.

https://doi.org/10.1182/blood.V126.23.5.5

Published: 2015

Journal Articles

Rare Genetic Variants Of The Protein-Coding Area Of The Genome and The Risk Of Inhibitor Development: An Exome-Sequencing Study Of 28 Patients With Severe Hemophilia A

Luca A. Lotta, Marco Fornili, Federico Ambrogi, Maria Elisa Mancuso, MD, PhD, Elena Santagostino, MD, PhD, Isabella Garagiola, Sabrina Seregni, Donna M. Muzny, Ginger Metcalf, Richard A. Gibbs, Elia Biganzoli, Flora Peyvandi

Blood (2013) 122 (21): 571.

https://doi.org/10.1182/blood.V122.21.571.571

Published: 2013

Journal Articles

Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura

Luca A. Lotta, Haifeng M. Wu, Ian J. Mackie, Marina Noris, Agnes Veyradier, Marie A. Scully, Giuseppe Remuzzi, Paul Coppo, Ri Liesner, Roberta Donadelli, Chantal Loirat, Richard A. Gibbs, April Horne, Shangbin Yang, Isabella Garagiola, Khaled M. Musallam, Flora Peyvandi

Blood (2012) 120 (2): 440–448.

https://doi.org/10.1182/blood-2012-01-403113

Published: 2012

Includes: Supplemental data

Journal Articles

Source and Purity of Factor VIII Products As Risk Factors for Inhibitor Development In Previously Untreated Patients with Severe Hemophilia A

Maria Elisa Mancuso, MD, PhD, Pier Mannuccio Mannucci, MD, Angiola Rocino, MD, Isabella Garagiola, Annarita Tagliaferri, Elena Santagostino, MD, PhD

Blood (2011) 118 (21): 25.

https://doi.org/10.1182/blood.V118.21.25.25

Published: 2011

Journal Articles

Type of Factor VIII Product as Inhibitor Risk Factor in Patients with Severe Hemophilia A and Null Mutations.

Maria Elisa Mancuso, MD, PhD, Pier Mannuccio Mannucci, MD, Angiola Rocino, MD, Isabella Garagiola, PhD, AnnaRita Tagliaferri, MD, Maurizio Margaglione, MD, Elena Santagostino, MD, PhD

Blood (2009) 114 (22): 3500.

https://doi.org/10.1182/blood.V114.22.3500.3500

Published: 2009

Journal Articles

ADAMTS-13 Binds Platelets through Gpib.

Andrea Artoni, MD, Rossana Lombardi, BSC, Isabella Garagiola, BSC, Flora Peyvandi, MD, Pier Mannuccio Mannucci, MD

Blood (2009) 114 (22): 3044.

https://doi.org/10.1182/blood.V114.22.3044.3044

Published: 2009

Journal Articles

Genotyp-Phenotype Correlation in Congenital ADAMTS13 Deficient Patients

Luca Andrea Lotta, Isabella Garagiola, Andrea Cairo, Robert Klaassen, MD, FRCP, Ayse Metin, Aytemiz Gurgey, Flora Peyvandi

Blood (2008) 112 (11): 273.

https://doi.org/10.1182/blood.V112.11.273.273

Published: 2008

Journal Articles

Non-Sense-Mediated mRNA Decay in ADAMTS13 Gene Caused by 29 Nucleotide Deletion.

Isabella Garagiola, PhD, Silvia Lavoretano, Hale Oren, Martina Bohm, Pier Mannuccio Mannucci, Flora Peyvandi

Blood (2006) 108 (11): 1061.

https://doi.org/10.1182/blood.V108.11.1061.1061

Published: 2006

Journal Articles

ADAMTS-13 Binds Platelets in a Specific, Divalent Cation and Activation Dependent Manner.

Andrea Artoni, MD, Isabella Garagiola, BS, Rossana Lombardi, BS, Flora Peyvandi, MD, Pier Mannuccio Mannucci, MD

Blood (2005) 106 (11): 2657.

https://doi.org/10.1182/blood.V106.11.2657.2657

Published: 2005

Journal Articles

The First Deletion Mutation in the TSP1-6 Repeat Domain of ADAMTS13 Leads to a Secretion Defect.

Flora Peyvandi, MD, PhD, Silvia Lavoretano, PhD, Roberta Palla, PhD, Isabella Garagiola, PhD, Carla Valsecchi, PhD, Rossana Lombardi, PhD, Maria T. Canciani, PhD, Pier M. Mannucci, MD

Blood (2005) 106 (11): 3960.

https://doi.org/10.1182/blood.V106.11.3960.3960

Published: 2005

Journal Articles

Localization and Function of Platelet ADAMTS-13.

Flora Peyvandi, MD, PhD, Isabella Garagiola, PhD, Andrea Artoni, MD, Rossana Lombardi, PhD, Roberta Palla, PhD, Raimondo De Cristofaro, MD, Pier Mannuccio Mannucci, MD

Blood (2005) 106 (11): 3967.

https://doi.org/10.1182/blood.V106.11.3967.3967

Published: 2005

Journal Articles

Highly Sensitive Chemiluminescent Method for the Detection of Maternal Cell Contamination in Human Cord Blood Stored for Allotransplantation: The Experience of the Milano Cord Blood Bank

Francesca Poli, Loretta Crespiatico, Lucilla Lecchi, Girolamo Sirchia, Mario Scalamogna, Silvia Maria Sirchia, Isabella Garagiola, Laura Pedranzini

Blood (1997) 89 (8): 3061.

https://doi.org/10.1182/blood.V89.8.3061

Published: 1997

NARROW

Genetic Variants Associated with High Plasma Levels of Factor VIII and Von Willebrand Factor in a Family with Thrombotic Episodes

Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis

Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A

Genetic Risk Stratification to Minimize Inhibitor Risk with the Use of Recombinant Factor VIII Concentrates: A Sippet Analysis

Risk Differential in Inhibitor Development in the First Days of Treatment By Product Class: A Sippet Analysis

Whole-exome sequencing to identify genetic risk variants underlying inhibitor development in severe hemophilia A patients

Source of Factor VIII Replacement (PLASMATIC OR RECOMBINANT) and Incidence of Inhibitory Alloantibodies in Previously Untreated Patients with Severe Hemophilia a: The Multicenter Randomized Sippet Study

Rare Genetic Variants Of The Protein-Coding Area Of The Genome and The Risk Of Inhibitor Development: An Exome-Sequencing Study Of 28 Patients With Severe Hemophilia A

Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura

Source and Purity of Factor VIII Products As Risk Factors for Inhibitor Development In Previously Untreated Patients with Severe Hemophilia A

Type of Factor VIII Product as Inhibitor Risk Factor in Patients with Severe Hemophilia A and Null Mutations.

ADAMTS-13 Binds Platelets through Gpib.

Genotyp-Phenotype Correlation in Congenital ADAMTS13 Deficient Patients

Non-Sense-Mediated mRNA Decay in ADAMTS13 Gene Caused by 29 Nucleotide Deletion.

ADAMTS-13 Binds Platelets in a Specific, Divalent Cation and Activation Dependent Manner.

The First Deletion Mutation in the TSP1-6 Repeat Domain of ADAMTS13 Leads to a Secretion Defect.

Localization and Function of Platelet ADAMTS-13.

Highly Sensitive Chemiluminescent Method for the Detection of Maternal Cell Contamination in Human Cord Blood Stored for Allotransplantation: The Experience of the Milano Cord Blood Bank

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only